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Kidney fibrosis is a devastating disease that leads to organ failure, and no 
specific treatment is available to preserve organ function. In fibrosis, 
myofibroblasts accumulate in the interstitium leading to massive 
deposition of extracellular matrix and organ disfunction. The origin of 
myofibroblasts is multiple and the contribution of renal epithelial cells 
after undergoing epithelial-to-mesenchymal transition (EMT) is still 
debated. In a model unable to reactivate the EMT inducer Snail1 upon 
damage, we show that Snail1 is required in renal epithelial cells for the 
development of fibrosis. Damage-mediated Snail1 reactivation induces a 
partial EMT that relays fibrotic and inflammatory signals to the interstitium 
through the activation of TGF-β and NF-B pathways. Snail1-induced 
fibrosis can be reverted in vivo and inhibiting Snail1 in a model of 
obstructive nephropathy highly ameliorates fibrosis. These results 
reconcile conflicting data on the role of EMT in renal fibrosis and provide 
avenues for the design of antifibrotic therapies. 
 
Kidney fibrosis is the main cause leading to end-stage kidney failure in most 
progressive renal diseases1 and the treatment of patients with end-stage renal 
disease cost only in the United States over $40 billion in 20092. Importantly, the 
treatments are almost limited to some form of dialysis or to kidney transplant, as 
specific non-invasive alternatives are still missing. The development of the renal 
system involves several rounds of epithelial to mesenchymal and in particular, 
mesenchymal to epithelial transitions (EMT and MET, respectively3). 
Importantly, the suppression of this plasticity in the adult is fundamental to 
maintain tissue architecture and homeostasis. Snail1, a potent EMT inducer 
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both during embryonic development and tumor progression4, is expressed in 
the precursors of the renal epithelial cells and it is downregulated upon 
epithelial differentiation and maintained silent in the adult5. We have previously 
shown that Snail1 reactivation in renal epithelial cells leads to renal fibrosis and 
renal failure in a tamoxifen-inducible Snail1 transgenic mouse model (Snail1-
ERT2)5. Snail1 is also reactivated in mice subjected to unilateral ureteral 
obstruction (UUO)6,7, a standard model for progressive renal fibrosis8 and we 
found that Snail1 was highly reactivated in fibrotic lesions obtained from 
patients subjected to nephrectomy5. Together, these data indicate that Snail1 
reactivation in adult kidneys is sufficient to induce renal fibrosis and that kidney 
fibrosis concurs with Snail1 activation in animal models and in patients. 
However, those observations do not address the question of whether Snail1 
reactivation, and in turn, the activation of an EMT-like program is required for 
renal fibrosis to develop. While initial cell fate tracing experiments described a 
significant contribution of renal epithelial cells to myofibroblasts9, subsequent 
studies could not find labeled epithelial cells within the interstitium10,11. Thus, we 
set out to directly assess whether the reactivation of Snail1 is not only sufficient 
but also required for the development of kidney fibrosis and whether its 
inhibition could have a significant impact on the disease. Using different mouse 
models we provide information on the mechanism behind Snail1 contribution to 
fibrosis. In addition, we show evidence of the activation of a partial EMT in 
epithelial cells that, without directly generating interstitial myofibroblats, relays 
crucial signals for the differentiation of this cell population and significantly 
impinges into the inflammatory response. This mechanism that, on one hand, 
leads to dedifferentiation of renal tubules while preserving its integrity and, on 
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the other hand facilitates interstitial fibrosis, also allows the regeneration of the 
damaged tubular epithelium. As such, we show that fibrosis can be reverted in 
vivo and that Snail1 inhibition significantly reverts renal fibrosis.  
 
RESULTS 
UUO-induced fibrosis is highly attenuated in kidneys that cannot 
reactivate Snail1 upon damage 
To directly assess the contribution of Snail1 reactivation in epithelial cells to 
renal fibrosis, we crossed Snail1loxp mice12 with a strain bearing the Ksp1.3-Cre 
transgene13. Ksp cadherin is also known as Cadherin-16, a kidney-specific 
cadherin expressed in the cortex and the medulla. The resulting strain, Ksp1.3-
Cre; Snail1f/f, will be referred to as SFKC hereafter (Supplementary Fig. 1) and 
impedes Snail1 expression in Cadherin-16 positive cells. We chose this model 
because Snail1 expression is silent in the adult kidney but it is reactivated after 
UUO both in the cortex and in the medulla (Supplementary Fig. 1). During 
renal development, the onset of expression of Cadherin-16 coincides with that 
of Snail1 downregulation. In fact, Snail1 is a strong Cadherin-16 repressor4, and 
it is only when Snail1 is downregulated that renal cells express Cadherin-16 
and epithelialization occurs. Therefore, preventing Snail1 expression in 
Cadherin-16 positive cells in the healthy adult kidney does not have any impact 
and the kidneys of these mice are completely normal. However, in contrast to 
the situation in wild type kidneys and as expected from the design of the 
experiment, SFKC mice were unable to reactivate Snail1 expression in renal 
epithelial cells in response to UUO (Fig. 1a,b). Analysis of overall morphology, 
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collagen deposition assessed by Sirius red staining and expression of alpha 
smooth muscle actin (-SMA) and vimentin shows that kidneys from SFKC 
mice are protected from the development of overt fibrosis after UUO, although 
signs of tubular distension resulting from the obstruction are readily evident 
(Fig. 1b). Quantitative analysis of epithelial and mesenchymal markers confirm 
the previously observed changes as a response to injury in wild type kidneys, 
changes that are very much attenuated in those from SFKC mice (Fig. 1c), 
particularly 2 weeks after UUO. These data indicate that Snail1 activation in 
renal epithelial cells significantly contributes to renal fibrosis.  
The decrease in epithelial markers, the increase in mesenchymal 
markers observed in wild type mice after UUO and the high attenuation of these 
features in SFKC mice is compatible with Snail1 reactivation in fibrosis acting as 
an EMT inducer.  If a full EMT program were activated in renal epithelial cells to 
contribute to myofibroblast, the prediction would be that those transformed 
epithelial cells were found in the interstitium. However, previous studies10,11 
failed to find these cells and a recent comprehensive cell tracing analysis of 
different kidney cells found a contribution of epithelial cells to the -SMA+ 
myofibroblast population that appears after UUO of only around 5%14. The latter 
is compatible with our findings in wild type obstructed kidneys where we 
observed a small population of epithelial-derived cells, as confirmed by residual 
lectin staining, that clearly showed a mesenchymal phenotype without showing 
signs of dying and that were not well integrated into tubules (Fig. 2a and 
Supplementary Fig. 2a). The small percentage of those mesenchymal cells is 
also in keeping with the observation that in our experiments the total number of 
tubules does not significantly differs between control and SFKC kidneys after 
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UUO, although the number of dilated tubules is significantly smaller in SFKC 
obstructed kidneys (Fig. 2b). All of this is indicative of a limited full EMT process 
during fibrotic response after ureteral obstruction. Nevertheless, UUO induces 
the loss of polarity/differentiation as seen by the disappearance of lectin 
expression in renal epithelial cells that have reactivated Snail1 (Fig. 2c). 
Epithelial cells also activate the expression of the Collagen I gene (Fig. 2d), 
which, as Snail2, is also downstream of Snail1 in the kidney5. This indicates that 
tubular epithelial cells can contribute to collagen deposition even if they are still 
integrated in the tubules and that UUO-induced Snail1 reactivation triggers a 
partial EMT in both cortical and medullar renal epithelial cells leading to 
damaged tubules and collecting ducts. As none of this occurs in the SFKC 
kidneys (Supplementary Fig. 2c,d), we conclude Snail1 reactivation in renal 
epithelial cells has a big impact on the development of fibrosis.  
 
Snail1 reactivation in the damaged kidney contributes to TGF-β signaling 
and inflammation 
Our previous results suggest that damaged Snail1-expressing renal 
epithelial cells not only can contribute to collagen deposition while being 
integrated in the tubules but also send signals to the interstitium. As such, 
injured epithelial cells produce TGF-β-containing exosomes that promote the 
proliferation and activation of interstitial fibroblasts15. TGF-β signaling is also 
important for the differentiation of myofibroblasts from bone marrow-derived 
mesenchymal stem cells15. In relation to this, we found that Tgf-β expression is 
dependent on Snail1 expression, as it is the activation of the TGF-β pathway in 
both epithelial and interstitial cells as measured by phospho-Smad2 staining 
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(Fig.3 a, b). Thus, the decrease in TGF-β signaling may explain the high 
decrease in the -SMA+ population in obstructed kidneys from SFKC mice (Fig. 
1b). As myofibroblasts are also involved in the recruitment of macrophages, we 
examined F4/80 expression and observed that the degree of macrophage 
colonization in SFKC kidneys was highly attenuated, as it also was the overall 
inflammatory response as indicated by the decreased levels of nuclear 
phospho-NF-kB (Fig. 3c). Taking advantage of the LacZ reporter allele in our 
SFKC mice, we found that phospho-NF-B labeling was only present in tubules 
that had not recombined (X-gal negative tubules) and therefore, they were 
competent to reactivate Snail1 (Fig. 3d). Altogether these data indicate that 
UUOinduced fibrosis concurs with a partial EMT of renal epithelial cells 
mediated by the reactivation of Snail1 which activates TGF-β and TGF-β 
pathways, impacting on interstitial fibroblast activation, macrophage recruitment 
and the inflammatory response, all required for the development and 
progression of organ fibrosis.  
 
Snail1-induced fibrosis can be reverted in vivo 
Considering the high degree of epithelial plasticity observed during embryonic 
development and cancer in terms of EMT and its reverse process MET16, we 
wanted to examine whether some plasticity also exists in fibrotic tissues.  As 
damaged renal epithelial cells are important for the development of fibrosis we 
chose to test this in the Snail1-ERT2 model that we generated previously5. 
These mice can activate Snail1 by nuclear translocation of the protein following 
tamoxifen administration, and the model is very appropriate to test potential 
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reversibility because these mice (i) develop renal fibrosis upon Snail1 
activation5 and importantly, (ii) it is renal epithelial cell-specific (Supplementary 
Fig. 3). Thus, we decided to test whether Snail1-induced fibrosis could be 
reverted upon Snail1 downregulation. First, using the same model of inducible 
Snail1 reactivation, we examined whether Snail1-induced EMT can be reverted 
upon tamoxifen removal in kidney cells in culture. MDCK-Snail1-ERT2 cells 
treated with tamoxifen translocated Snail1 protein to the nucleus and 
undergone EMT. This transition was reverted after tamoxifen removal, 
concomitant with the absence of nuclear Snail1 and the recovery of epithelial 
morphology (Supplementary Fig. 4).   
 Next, we tested whether Snail1-induced fibrosis could be attenuated in 
vivo (Fig. 4a). As we had observed in kidney cells in culture, Snail1 protein can 
efficiently shuttle from the cytoplasm to the nucleus upon tamoxifen 
administration and it is detected back in the cytoplasm after tamoxifen removal 
(Fig. 4b). Fibrosis progresses with the time of tamoxifen exposure (8 versus 16 
weeks, panels 2 and 3, respectively, in Fig. 4b) as seen by histology, Sirius red 
staining and changes in the expression of mesenchymal and epithelial markers 
detected either by immunostaining or gene expression analyses. Fibrosis also 
progresses with the activation of Tgf-β gene expression and an increase in the 
inflammatory response (nuclear pNF-B) (Fig. 4b,c). All these features are 
highly attenuated after 8 weeks of tamoxifen removal. Particularly, collagen 
deposition, mesenchymal markers, Tgf-β expression and inflammation almost 
return to basal levels (Fig. 4b,c, compare panels 4 with 1 and real time RT-PCR 
data in the same groups). Furthermore, renal function assessed by the levels of 
creatinin clearance also shifted back to normal after being  decreased upon 8 or 
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16 weeks of Snail1 reactivation. Altogether, these data indicate that Snail1 is a 
very potent inducer of fibrosis, and that this fibrosis can be reverted in vivo. 
However, this experimental design does not address whether renal fibrosis 
developed as a response to natural stimuli including damage could also be 
reverted after inhibiting Snail1.  
 
Ureteral obstruction-induced fibrosis can be reverted by inhibiting Snail1 
In order to examine whether inhibiting Snail1 could be beneficial in a more 
physiological context than the Snail1-ERT2 mice, we decided to inhibit Snail1 
function in the UUO model. Seven days after UUO, when mice had already 
developed fibrosis, we injected VIVO-morpholinos designed against a splicing 
site in the Snail1 mRNA (Fig. 5a; Supplementary Fig. 6 and Methods), which 
allowed us to test the levels of the correctly spliced isoform and those in which 
exon 2 was missing. Therefore, we could assess the efficiency of the 
Morpholino in blocking Snail1 expression in each individual mouse, and 
compare this with the progression of fibrosis (Supplementary Figure 6). When 
we compared mice subjected to UUO for 7 days and then treated with either 
control morpholino (Control-MO) or one designed against Snail1 mRNA (Snail1-
MO), we observed a significant amelioration in fibrosis only in the Snail1-MO 
injected mice. Kidneys presented a recovered morphology a decrease in 
collagen deposition, and in vimentin and -SMA expression in Snail1-MO 
treated mice (Fig. 5b). Similarly, expression analysis of transcripts indicated 
that the levels of Snail1, Snail2 and vimentin were significantly downregulated 
when compared with those in obstructed kidneys from mice injected with 
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Control-MO (Fig. 5c). Furthermore, as suggested in our analyses of the SFKC 
mice, Snail1 had a big impact in TGF-β expression and macrophage 
colonization and inflammation (Fig. 5b,c), as all these responses were highly 
attenuated upon Snail1 inhibition. These results indicate that the amelioration in 
fibrosis observed in our mice is specific for Snail1 downregulation as it does not 
occur after Control-MO injection or even after the injection of Snail1-MO in mice 
in which the morpholino did not efficiently blocked normal mRNA splicing 
(Supplementary Fig. 6). In summary, this data indicate that Snail1 inhibition 




Renal fibrosis and organ failure is the end-stage of multiple chronic kidney 
diseases (CKD) that can result from urinary obstruction, autoimmune disorders, 
unresolved inflammation or deterioration of transplants1. In spite of the efforts 
invested no specific therapy is still available and the intimate mechanisms that 
drive interstitial fibrosis are still under debate, as conflicting results have either 
assigned an important or a negligible role of tubular EMT in the progression of 
renal fibrosis9-11,17,18. In addition, inflammatory cytokines and inflammatory cells 
are the principal effectors of the chronic disease19, but the mechanisms by 
which chronic inflammation impinges into fibrogenesis still remain unclear. 
Understanding this link is envisaged as key in the design of therapeutic 
strategies to halt the progression of CKD20. Using renal epithelial-specific 
mouse models, and in particular modifying Snail1 expression in medullar and 
cortical renal epithelial cells, we have provided evidence of the contribution of 
EMT and the link between inflammation and fibrosis.  
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With respect to the EMT, we show that (i) a partial EMT of renal epithelial 
cells is activated upon renal damage, (ii) these damaged cells mainly remain 
integrated in the tubules while relaying fibrogenic and inflammatory signals that 
lead to the progression of the disease, and (iii) both fibrogenesis and 
inflammation require the activation and maintenance of the potent EMT inducer 
Snail1. Therefore, our results highlight the importance of an EMT-like program 
in renal epithelial cells for the development of fibrosis. They also reconcile 
previous conflicting results on the role of EMT9-11 in this process, confirming the 
limited contribution of a full EMT program that delivers transformed epithelial 
cells to the interstitium14. Importantly, the partial EMT undergone by renal 
epithelial cells and the persistence of the damaged tubules explains the high 
degree of cell plasticity that we observed in vivo, as we show that Snail1 
inactivation in a Snail1-induced fibrosis model leads to the recovery of renal 
morphology and function.  In relation to this, during TGF-β-induced EMT in 
cancer cells, the mutual antagonism between Snail1 and miR-34, has been 
recently considered as a reversible switch, pointing to the possibility of 
reversion to the epithelial phenotype21 and miR-34c has been shown to 
attenuate UUO-induced fibrosis22. Furthermore, our data help to better 
distinguish type2 EMT, previously ascribed to fibrosis and wound healing, from 
type3 EMT23, associated with cancer cell delamination from the primary tumor. 
In the partial EMT that occurs in type2, damaged adult epithelial cells remain 
confined in their tissue of origin, while a full EMT in cancer (type3) endows cells 
not only with the ability to invade adjacent territories but also with that of 
intravasating into blood vessels to disseminate and later populate distant 
organs16. 
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With regard to the link between fibrosis and inflammation we find that it 
also relies on the reactivation and, particularly, on the maintenance of Snail1 
expression in epithelial cells. UUO induces the activation of TGF-β and NF-B 
signaling pathways, key for fibrogenesis and inflammation, respectively, and the 
main drivers of CKD and other fibrotic processes24,25. The initial inflammatory 
response after UUO leads to TNF- production, which induces the activation of 
NF-B (reviewed in ref. 25). In addition to inflammation, NF-B also impinges 
into Snail1 expression by directly inducing its transcription and the stabilization 
of the Snail1 protein26. TGF-β is first secreted to control the inflammatory 
response, but in the context of chronic injury as in fibrosis, it becomes fibrogenic 
and the most potent Snail inducer4.  Thus, both signaling pathways converge in 
Snail1 and we find Snail1 activation and maintenance is required for the 
progression of fibrogenesis and for sustained inflammation. This indicates that 
Snail1 may establish positive feedback loops reinforcing both the fibrogenic and 
inflammatory responses. As such, we show that Snail1 is required for the 
maintenance of Tgf-β expression and in a context of activated NF-B, Snail1 
can mediate the induction of inflammatory cytokines, as observed in cancer 
cells27. Altogether, this explains why in the absence of Snail1, as in our SFKC 
model, both fibrogenesis and inflammation are highly attenuated, indicating that 
the partial EMT activated by Snail1 in renal epithelial cells is instrumental for the 
progression of renal disease. 
Following the previous observations, Snail1 should behave as a 
promising therapeutic target. As such, we find that after UUO Snail1 inhibition 
by systemic injection of antisense oligonucleotides very significantly ameliorates 
fibrosis. Inhibiting EMT/inflammation by dowregulation of either TGF-β28,29 or 
	 13
NF-B30,31 signaling pathways have provided hope for antifibrotic treatments, 
but the pleiotropic roles of both pathways, particularly the associated beneficial 
effects, limit the potential use of their inhibitors in systemic administration 
protocols32,33. Given that Snail1 is maintained almost silent in healthy adult 
tissues16, its inhibition should not cause undesirable side effects. Our data also 
provide a window of opportunity for the EMT inhibitors that are being developed 
for anti-metastatic therapies and that have been recently challenged by the 
demonstration that cancer cells need to revert to the epithelial phenotype for 
successful metastatic colonization34,35. As such, inhibiting EMT in cancer 
patients may be counterproductive. By contrast, the mesenchymal phenotype is 
the end stage in organ fibrosis and the reversion to the epithelial state should 
be fully beneficial. Therefore, we propose that Snail1 is located at the center of 
a “core” pathway in fibrosis, defining “core” as a pathway which targeting is 
sufficient to limit the progression of the disease32. In summary, inhibiting EMT 
and Snail1 in particular can be regarded as a safe strategy to ameliorate 
fibrosis, especially in fibrotic processes where inflammation plays an important 
role in the progression of the disease.   
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Figure 1.  Snail reactivation is required for the development of UUO-induced 
fibrosis. (a) Scheme of the experimental approach. UUO was conducted in wild 
type (WT) or Ksp1.3-Cre;Snail1fl/fl (SFKC) mice, which were sacrificed 7 or 15 
days after obstruction. (b) Kidney sections taken from sham-operated (control) 
	 18
and obstructed kidneys (UUO) of WT and SFKC mice 7 days after surgery, 
were subjected to in situ hybridization for Snai1 expression; hematoxilin-eosin 
(H/E) and Sirius red stainings, and alpha smooth muscle actin (α-SMA) or 
vimentin immunohistochemistry. Tissue sections are representative of 8 
independent samples examined from each of 6-8 mice per group. (c) Snail1, 
Snail2, E-cadherin, Cadherin-16 and Vimentin mRNA levels determined by 
qRT-PCR in obstructed (L) and in contralateral non-obstructed kidneys (NL) 
from both WT and SFKC mice 7 or 15 days after UUO. Data are normalized to 
sham-operated wild type levels and represent mean ± SEM for groups of 6–8 
mice. **p < 0.01, ***p < 0.001, ****p < 0.0001, ns, non-significant. 
 
Figure 2.  Renal epithelial cells dedifferentiate after UUO. (a) Cell polarity is 
affected in the proximal and distal tubular epithelia after UUO. Double 
immunohistochemistry for LTA lectin (marker of proximal tubules; PT) and PNA 
lectin (marker of distal tubules; DT) and TUNEL staining identified cells 
undergoing apoptosis. Hematoxylin staining (HE) and TUNEL panels show the 
same sections taken from kidneys of 8-week old WT mice that were sham-
operated (control) or subjected to obstruction (UUO), both sacrificed 7 days 
after the intervention. Damaged tubules downregulate lectin expression (see 
also Supplementary Fig. 2b). The fields are selected to illustrate lectin positive 
cells that are not integrated into the tubules, depict a mesenchymal phenotype 
and show internalized (non-polarized) lectin expression (stars). These cells 
represent a small percentage of renal epithelial cells (less than 5%) and they 
are TUNEL negative.  (b) Number of dilated and total tubules in wild type (WT) 
and SFKC kidneys 15 days after UUO. 10 different fields were counted in 12 
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independent mice per condition. Data represent mean ± SEM. *p < 0.05; ns, 
non-significant.  (c) Lectin staining (LTA), in sections from the same kidneys 
used in panel a, is downregulated in tubules that have reactivated Snail1 
expression as shown by immunofluorescence. (d) Collagen type I gene 
expression (blue; stars) and LTA (brown) determined by in situ hybridization in 
kidneys from 8-week old wild type (WT) mice 7 days after UUO. Collagen type I 
gene is transcribed after UUO in wild type mice in epithelial and interstitial renal 
cells. Tissue sections are representative of 6 independent samples examined. 
 
Figure 3. Snail1 reactivation in renal epithelial cells contributes to fibrosis by 
inducing TGF- and an inflammatory response in the injured kidney. The 
experimental design is the same as in Fig. 1. (a) Tgf- mRNA levels determined 
by qRT-PCR in obstructed (L) and contralateral control (NL) kidneys from wild 
type and SFKC mice 7 or 15 days after surgery. Data are normalized to sham-
operated wild type levels and represent mean ± SEM for groups of 6–8 mice. 
****p < 0.0001, ns, non-significant. (b) Phospho-Smad2 (p-Smad2) stainings in 
representative sections from sham-operated (control) and obstructed kidneys 
(UUO) from WT or SFKC mice collected 7 days after surgery (c) 
Immunolabeling for F4/80 (macrophage marker) and phospho-NF-B (pNF-B) 
in samples from the same experiment shown in panel b. (d) X-gal and pNF-B 
staining in obstructed kidneys from SFKC mice. Tissue sections are 
representative of 6 independent samples examined per mouse (n=6).  
 
Figure 4.  Snail1-induced fibrosis can be reverted in vivo. (a) Scheme of the 
experimental approach. Mice were treated with (1) vehicle (corn oil, –TAM); (2) 
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tamoxifen for 8 weeks (+TAM); (3) tamoxifen for 16 weeks (+TAM+TAM), and 
(4) tamoxifen for 8 weeks followed by vehicle treatment for another 8 weeks 
(+TAM-TAM). Additional control experiments including treatment of wild type 
mice are shown in Supplementary Fig. 5. (b) Anti-human estrogen receptor 
(hER) staining showing exogenous Snail1 protein expressed in the cytoplasm of 
the transgenic kidneys (-TAM) and translocated to the nucleus upon tamoxifen 
administration (+TAM; +TAM+TAM). Snail1 is detected back in the cytoplasm 
after 8 weeks of tamoxifen removal (+TAM-TAM). Panels show hematoxilin-
eosin (H/E) and Sirius red staining, and alpha smooth muscle actin (α-SMA), 
vimentin and phospho-NF-B (pNF-B) immunohistochemistry. Levels 
approach control levels upon tamoxifen removal. Tissue sections are 
representative of 6 independent samples examined. (c) mRNA levels detected 
by qRT-PCR in transgenic kidneys showing an increase in Snail2, Vimentin and 
Tgf- mRNA levels and a decrease in E-Cadherin and Cadherin-16 mRNA 
abundance upon Snail1 activation ((2;+TAM and 3;+TAM+TAM) and a return to 
levels close to the baseline after 8 weeks of tamoxifen removal (4:+TAM-TAM). 
Data are normalized to vehicle treated kidney levels (1; -TAM) and represent 
mean ± SEM for groups of 6–8 mice. *p< 0.05, **p < 0.01, ***p < 0.001, ****p < 
0.0001, ns, non-significant. 
 
Figure 5. Snail inactivation reverts UUO-induced fibrosis in mice. (a) Scheme of 
the experimental approach. Seven days after UUO, mice were injected with 
vivo-morpholino control (Control-MO) or Snail1-MO1 (Snail1-MO) every other 
day. (b) Hematoxilin-Eosin (H/E) and Sirius Red staining; expression of 
mesenchymal (vimentin and alpha smooth muscle actin (-SMA)); and 
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inflammatory response markers (F4/80 and phospho-NFkB (pNFkB)) 
immnunohistochemistry in kidney sections from mice in panel a. Note the 
recovered morphology and epithelial markers expression together with 
decreased inflammation in obstructed kidneys injected with Snail1-MO. (c) qRT-
PCR from obstructed kidneys treated with Snail1-MO shows a decrease in 
UUO-induced Snail1 and Snail2 mRNA levels, a highly diminished expression 
of the mesenchymal marker vimentin and of Tgf-β) plus a partial recovery of E-
Cadherin and Cadherin-16 transcripts. Data are normalized to contralateral non-
obstructed kidney levels (NL) and represent mean ± SEM for triplicates of data 
from a representative mouse in which Snail1-MO efficiently induced exon-
skipping and therefore, subsequent Snail1 downregulation. *p< 0.05, **p < 0.01, 
***p < 0.001, ****p < 0.0001, ns, non-significant. 
 
METHODS 
Methods are included in Supplementary information 
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Supplementary Figure 1. Epithelial recombination mediated by Ksp1.3‐Cre as assessed by crossing
the mice with the Rosa26R (R26R) reporter strain. (a) Whole‐mounted X‐gal stained kidneys from
Ksp1.3Cre;R26R newborn and adult mice (2‐month‐old) to detect β‐galactosidase activity as an
indication of Cre recombination. Recombination is detected in both kidney cortex and medulla. No
staining is detected in kidneys from a transgenic mouse carrying only the lacZ reporter gene. (b) X‐
gal staining in sections obtained from SFKC;R26R kidneys and co‐staining with different lectins,
markers of proximal tubules (LTA) or distal tubules (PNA). Asterisks indicate examples of double
positive tubules in the latter. Anti‐Tam‐Horsfall protein antibodies mark the thick ascending limb of
Henle (TH). X‐gal (β‐galactosidase) staining is also prominent in the collecting ducts of the medulla.
G indicates glomeruli. Ksp1.3Cre mediates recombination in collecting ducts, loop of Henle, the
majority of proximal tubules and in some distal tubules. (c) Snail1 expression is reactivated after



















































































































Supplementary Figure 2. (a) High power magnification of two photomicrographs shown in Fig. 2a to
better assess the position and morphology of mesenchymal cells. Stars indicate the position of these
cells. (b) Low and high magnification images of sections taken from Sham‐operated (control) and
obstructed kidneys (UUO) from wild type and SFKC mice to better appreciate morphology together
with lectin expression. Wild type kidneys undergo massive lectin loss although tubules are still
present. SFKC kidneys maintain lectin expression and the number of dilated tubules is decreased. G
indicates glomeruli. (c) No cell death is detected in SFKC kidney sections after seven days of UUO as
assessed by TUNEL. (d) PNA (brown, detected by immunohistochemistry) and Snail1 (blue, detected
by in situ hybridization) expression is not induced in SFKC kidneys after UUO. Stars indicate Snail1
expression.
+TAM  Snail1 active-TAM Snail1 inactive
Supplementary Fig. 3. The Snail1‐ERT mouse model is specific for renal epithelial cells.
Transgenic Snail1 protein is translocated from the cytoplasm to the nucleus upon tamoxifen

























Supplementary Figure 4. (a) MDCK cells (dog renal cells) were transfected with the Snail1
tamoxifen inducible construct used to generate the Snail‐ERT2 transgenic mouse line. (b) Cells
were treated with 4‐Hydroxytamoxifen (4’OH‐TAM) for 72 hours and fixed for
immunofluorescence analysis. Note that Snail1 is detected in the nucleus and cells have adopted
a mesenchymal phenotype. (c) Cells were washed after 4’OH‐TAM treatment and left in culture
for an additional 72 hours period. Snail1 is absent from the nuclei and cells recover E‐cadherin
expression and lose mesenchymal morphology. 4’OH‐TAM (200 ng/ml), the synthetic ligand
recognized by the ligand‐binding domain of the human estrogen receptor in our construct was



































Snail2 E‐cadherin VimentinCadherin‐16 TGF‐
Supplementary Figure 5. (a) WT mice were treated with tamoxifen or corn oil (vehicle) in parallel
to the treatments performed in Snail1‐ERT2 mice shown in Fig. 4. (b) Stainings in 5 µm paraffin
sections from wild type mice kidneys treated with corn oil (5), tamoxifen for 8 weeks or 16
weeks (6 or 7), or tamoxifen for 8 weeks followed by oil treatment for another 8 weeks (8).
Hematoxilin‐eosin (H/E) and Sirius red staining do not show any sign of fibrosis. Tissue sections
are representative of 6 independent samples examined per mouse (n=4 per condition). (c) Snail2,
E‐cadherin, Cadherin‐16, vimentin and TGF‐ mRNA levels detected by qRT‐ PCR from WT kidneys
does not detect any significant difference between treatments Data are normalized to vehicle






























































































































































































































Supplementary Figure 6. (a) RT‐PCR analysis of Snail1 transcripts expressed in obstructed kidneys
after treatment with Vivo‐morpholinos designed to induce exon skipping in Snail1 mRNA. The full‐
length product amplified from the normal transcript is 770 base pairs (bp), and the product missing
exon 2 is 242 bp. Two VIVO‐morpholinos (MO) were designed as described in Online methods. MO1
efficiently induced exon skipping in 80% of injected mice (4/5), while MO2 only partly worked in 2/4
injected mice. (b and c) Panels show data from the mouse in which MO1 did not work as assessed by
its failure in inducing exon skipping (MO1.2 in a). Samples were treated as those from the mice in
which MO1 effectively led to exon skipping (4/5; example of one of these mice is MO1.1 in a, and the
corresponding data are shown in Fig. 5). Hematoxilin‐Eosin (H/E) and Sirius red staining,
immunohistochemistry for mesenchymal markers (vimentin and alpha smooth muscle myosin; αSMA)
and inflammation markers (F4/80 and phospho‐NFkB (pNFkB) do not show significant differences
between the mouse injected with MO1 or Control MO (panel b). qRT‐PCR analysis fails to show
significant differences in mRNA abundance except for TGF‐, which coincides with higher NFkB
activation. We cannot discard that the injection of Snail1MO1 induced an inflammatory response that
does not occur after injection of the control MO. This response is abolished when Snail MO1
efficiently induced exon skipping, further supporting the role of Snail1 in inflammation in the renal
system. Data are normalized to contralateral non‐obstructed kidneys (NL) and represent the mean ±
SEM of triplicates (n = 5). ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001.




Mice. Animals were housed under SPF conditions at the RMG animal House 
(ES-119-002001 SEARMG). Work with GMO was under the A1ES/13/1-25 
license. To specifically inactivate Snail1 in renal epithelial cells, we generated a 
mouse line with kidney-specific inactivation of Snail1 by crossing females from 
the snail-floxed line (Snai1fl/fl)1 with the Ksp-Cre transgenic strain obtained from 
Peter Igarashi´s lab2. R26R mice (Gtrosa26tm1Sor) were obtained from 
Jackson Laboratories. To examine the efficiency of recombination, 
heterozygous female Snail floxed mice (Snail1fl/+) were crossed with 
heterozygous male mice that express Ksp1.3-Cre transgene. From the filial (F) 
1 progeny, mice (male or female), litters with heterozygous deletion of Snai1 
gene that harboured the Ksp1.3/Cre transgene (Snail1fl/+; Ksp1.3-Cre) were 
selected and they were further crossed with the opposite sex of Snail1 floxed 
mice (Snai1fl/+) to obtain mice expressing complete deletion of Snail1 in the F2 
progeny (Snai1fl/fl;Ksp1.3-Cre), referred to as SFKC. Compared to control 
(Snail1fl/fl) littermates, SFKC mice are viable, display no overt defects, and 
survive to 6 months and beyond with no ill effects. The generation of the 
tamoxifen-inducible Snail1 transgenic mouse has been described previously3 
where the transgenic Snail1-ERT2 protein was specifically expressed in renal 
epithelial cells (Supplementary Fig. 3). In this model, constitutively expressed 
exogenous Snail1 protein only becomes active on nuclear translocation. For 
tamoxifen inductions, the tamoxifen was dissolved in corn oil 30 mg/ml and 
mice (8 weeks-old) were intraperitoneally injected with 200 mg of tamoxifen per 
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gram of body weight or a similar volume of corn oil every 3 days for 8 or 16 
weeks. Animals were killed by cervical dislocation and their kidneys processed 
for mRNA extraction, ISH or immunohistochemistry. All procedures were 
conducted in strict compliance with the European Community Council Directive 
(89/609/EEC) and the current Spanish legislation. Ethical protocols were 
approved by the CSIC Ethical Committee and the Animal Welfare Committee of 
the Instituto de Neurociencias. 
 
UUO model. Mice (8 weeks-old) were anesthetized with an intraperitoneal 
injection of ketamine (100 mg/kg) and xylacine (10 mg/kg). The abdomen was 
opened, and the left ureter was ligated with 5-0 silk. The abdomen was then 
closed with running sutures and the skin was closed with interrupted sutures. 
After surgery, the mice were maintained in a temperature-controlled room with a 
12 hours light/dark cycle, and were reared on standard chow and water ad 
libitum. Unilateral ureteral obstruction (UUO) was maintained for 7 or 15 days.  
 
Renal function. Twenty-four-hour urine was collected from tamoxifen-inducible 
Snail1 transgenic mice, at baseline and after 8 or 16 weeks of tamoxifen or 
vehicle administration. Animals were housed in a metabolic cage for collection 
of urine to determine creatinine concentration and urine volume. Creatinine and 
acid uric was also measured in the blood obtained through the saphenous vein. 
 
Morpholino oligomer and in vivo treatment. The oligonucleotides sequences 
5′-TGAACTCTGCGGGAAGAGAAGAGAC-3′ VM1 against the boundary 
sequences of the intron 1 and exon 2 and 5´- 
	   3	  
GCTATGCACACTCACTCACCAGTGT-3´ VM2 against the boundary 
sequences of the exon and intron 2 of Snail1 gene were synthesized as 
Morpholinos by (Gene Tools). Vivo-Morpholinos were made by conjugation of 
an unmodified Morpholino with a synthetic scaffold featuring eight guanidinium 
head groups. A control antisense that targets a human β-globin intron mutation 
5′-CCTCTTACCTCATTACAATTTATA-3′ was used as vivo-morpholino standard 
control, VMC. C57/Bl6 mice aged 8 weeks were subjected to UUO and 7 days 
after obstruction they were injected every other day until day 15. A solution of 
containing vivo-Morpholinos in saline (100 µL; 6mg MO/kg) was injected in the 
tail vein of the corresponding mice. 
 
In situ hybridization. In situ hybridization was performed as previously 
described3. Briefly, mouse kidneys were fixed overnight in 4% PFA in PBS and 
processed directly for paraffin embedded. 12 µm sections were de-paraffinized 
and rehydrated, treated with proteinase K and fixed with 4% paraformaldehyde. 
Digoxigenin-labeled RNA probes were detected by alkaline-phosphatase-
coupled anti-digoxigenin antibody (Roche Diagnostics, Mannheim, Germany) 
and NBT/BCIP was used as a chromogenic substrate to detect the digoxigenin-
labeled probes (Boehringer, Mannheim, Germany). Sections were mounted in 
50% glycerol in PBS and slices were photographed with a Leica DMR 
microscope under Nomarski optics. 
 
Histological analysis. Kidney tissues were fixed in 4% PFA in PBS for 24 
hours and embedded in paraffin. 3-µm sections were cut using a paraffin 
microtome with stainless steel knives. The sections were mounted on glass 
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slides, deparaffinized with xylene, dehydrated through graded series of ethanol, 
and stained with hematoxylin-eosin. To evaluate collagen deposition, sections 
were stained with Sirius Red (saturated aqueous solution of picric acid 
containing 0.1% Direct Red 80) (Sigma-Aldrich, St Louis, MO). 
 
Immunohistochemical studies. Paraffin sections were deparaffinized and 
hydrated in graded ethanol series before staining with the peroxidase–
antiperoxidase method. Antigens were retrieved by boiling for 20 min in 10mM 
citric acid solution (pH=6) or 10 mM Tris- 1 mM EDTA (pH=9). Endogenous 
peroxidase was blocked by incubation in 4% hydrogen peroxide. The sections 
were incubated overnight at 4ºC with the following primary antibodies: 
Biotinylated Lotus Tetragonolobus agglutinin, LTA (B-1325, Vector 
Laboratories, Burlingame, CA); Biotinylated Peanut agglutinin, PNA (B-1075, 
Vector Laboratories, Burlingame, CA); Tamm-Horsfall glycoprotein, THP (sc-
20631; Santa Cruz Biotechnology, Santa Cruz, CA); alpha-smooth muscle 
actin, α-SMA (Sigma-Aldrich, St Louis, MO); Vimentin (sc-7557, Santa Cruz 
Biotechnology, Santa Cruz, CA); Phospho-NF-κB p65 (Ser276) (3037S, Cell 
Signaling Technology, Inc., Danvers, MA); Phospho-Smad2 (Ser465/467) 
(3101S, Cell Signaling Technology, Inc., Danvers, MA); F4/80 (MCA497GA, 
Serotec, Oxford,UK); Estrogen receptor alpha, ERα (sc-543, Santa Cruz 
Biotechnology, Santa Cruz, CA); Von Willebrand Factor, vWF (ab68545, 
Abcam, Cambridge, UK). The sections were incubated with the correspondent 
biotinylated secondary antibody, and sequentially incubated in ABC-Peroxidase 
Solution (Thermo Scientific, Rockford, IL) and 3,3'-Diaminobenzidine (DAB) 
(Sigma-Aldrich, St Louis, MO) was used as chromogen. Sections were lightly 
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counterstained with hematoxylin and were dehydrated and coverslipped. 
TUNEL staining was performed on sections using the In Situ Cell Death 
Detection Kit, (Roche Diagnostics GmbH, Mannhelm, Germany) according to 
the manufacturer's instructions. 
 
X-Gal Staining. Kidneys were fixed in 4% paraformaldehyde in PBS for 2 hours 
on ice and stained for β-galactosidase activity by incubation in PBS containing 2 
mM MgCl2, 5 mM K4Fe(CN)6, 5 mM K3Fe(CN)6, and 0.4 mg/ml X-gal overnight 
at 37°C. After staining, the kidneys were washed in PBS and further fixed in 4% 
paraformaldehyde in PBS at 4°C. Kidneys were embedded in paraffin and 5 µm 
sections were cut, mounted and photographed with a Leica DMR microscope. 
In some experiments tissue sections were sequentially stained with antibodies 
or lectins as described above. 
 
Quantitative RT-PCR (qRT-PCR). Total RNA was extracted using the Illustra 
RNAspin Mini RNA isolation kit (GE Healthcare, Little Chalfont, UK). 1µg of 
RNA was reverse transcribed using random hexamer primers according to the 
manufacturer’s instructions (SuperScript II, Invitrogen). qRT-PCR was carried 
out on an ABI PRISM 7000 sequence detection system using the SYBR Green 
method (Applied Biosystems). RNA expression was calculated using the 
comparative Ct method normalized to Eif3. Data were expressed relative to a 
calibrator using the 2-(∆∆Ct) ± s formula.  
 
Data analysis. Statistical analysis was performed using the GraphPad Prism 
software package. Results were expressed as mean ± SEM (standard error of 
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mean). Differences among different groups were tested by One-Way ANOVA or 
Two-Way ANOVA followed up by Tukey's test as appropriate. Differences 
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